Transmissible spongiform encephalopathies (scrapie, BSE, Kuru) develop as CNS diseases after long incubation periods, and many of which may arise following the consumption of infected material. The infectious agent is thought to be a mis-folded 
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Introduction: Prions and the oral transmission of TSE
The oral route of infection has been implicated in the pathogenesis of transmissible spongiform encephalopathy (TSE), a disease that targets clinically the central nervous system (CNS). Spread of the disease, both naturally and experimentally, by ingestion of the infectious agent has been described in a variety of species ranging from domestic, as well as wild-life, animals to man [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . The likelihood of spread of the bovine form of TSE (BSE) [11] to human (nvCJD) through the food-chain [6] has aroused long-lasting public health anxiety with adverse economical and political consequences, both in the UK and abroad for the last decade [12] [13] [14] . Due to the long incubation period of the illness, infected individuals may remain asymptomatic for years. It remains still highly uncertain as to how risky it has been, or how safe it is now, to eat beef or even meat from other animals likely to carry and pass on the mysterious 'mad cow' disease [7, 15] .
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The disease has also led to the proposition of a novel mechanism of infectivity: that is an infectious agent (TSEA) possibly devoid of nucleic acid. This was first indicated by its refractoriness to UV irradiation [16] . It is also complicated by the many other unusual physical and biological properties of the molecules including, most worryingly, its extraordinary resistance to conventional sterilization procedures. The exact nature of the etiologic agent has been, and still is, a focus of scientific debate.
Although the possible causal agent being an "unconventional slow virus" (Virino Theory) [17] is not excluded [18] , live virus of this kind has not been isolated. The lack of specific immune response to the puzzling agent [19] , and the absence of inflammatory cell infiltrate in the affected brains, seem to suggest otherwise [20, 21] . PrP Sc , also known as 'scrapie-associated prion protein', is an abnormally folded, selfencoded protein (PrP C ) that co-purifies with TSE infectivity [22, 23] . The molecule is now considered to be the crucial, if not the only agent (Protein Theory), responsible for the infection [24] . Structurally, PrP
Sc is rich in β-sheets, in contrast to the α-helixrich PrP C , and is insoluble in many detergents. The current hypothesis suggests that the pathogenesis involves a key step of prion protein conversion and replication in which PrP Sc converts the normal protein, PrP C , into the abnormal form [25] . The agent replicates in this way by a post-translational alteration of the tertiary structure (conformational change), but not amino acid sequence, of the host-encoded protein, turning it into a highly self-aggregating, protease-resistant pathological isoform [26, 27] . 
The immune system in prion diseases
A long incubation period preceding the neurological symptoms is common to all
TSEs. Much evidence indicates that TSEA replication as described above is essential for the development of clinical disease and that such replication occurs, at least primarily, in the immune system.
In spite of the lack of any signs of an immune response, it has been known for a long that the immune system plays a crucial role in TSE pathogenesis [31] . Splenectomy of mice before infection significantly prolongs the incubation period of the disease after peripheral inoculation [32, 33] , as does genetic asplenia [34] , but athymia and neonatal thymectomy have no effect [33] . Severe combined immunodeficient (SCID) mice lacking mature T and B lymphocytes fail to develop the disease [32] , but become susceptible after reconstitution with normal splenocytes [35] .
Immunosuppressive drugs can prolong the incubation time of the disease [36], whereas stimulation of the lymphoid systems with mitogens enhances disease susceptibility [37] .
Following peripheral infection, PrP Sc is detected in the spleen, lymph nodes and other lymphoid tissues long before CNS involvement [38] [39] [40] . The spleen however may not be the main organ involved in infection via the oral route, infectivity being found first in the Peyer's patches [39] . This suggests that the gut-associated lymphoid tissues 
Follicular dendritic cells as the site for prion propagation
The cell type(s) likely to be involved in propagation of prions are thought to be of low [59] suggests it is also possible that PrP may act as an autoligand.
Based on findings from several genetically modified mouse models, however, other groups of investigators argued that B cells [60] , and possibly other unidentified cells [61] , might be also crucial in peripheral prion transmission. The authors demonstrated that mice devoid of B, but not T, cells were resistant to disease inoculation via peripheral routes, while the animals remained equally sensitive to infection by intracerebral injection [62] . The same group reported subsequently that PrP expression in B lymphocytes was not required for prion neuroinvasion, since immunological constitution with haematopoietic precursors from PrP knock-out donors restored sensitivity to disease induction [60] . One explanation may be that B cells are not directly involved in replication but rather transport of the agents.
Alternatively, the lack of B cells or B cell products may prevent FDC maturation and differentiation [63, 64] . By using chimeric mouse models mismatched in PrP status between FDCs and other cells of the immune system, Brown and colleagues showed that replication of prions in the spleen depends on PrP-expressing FDCs rather than on lymphocytes or other bone marrow-derived cells, and that the contribution of B cells is related to their ability to induce the functional maturation of FDCs [65] . The role of FDCs in TSE pathogenesis, at least acting as the primary sites for prion replication, is once again emphasized and largely comfirmed.
Entry and transport of orally-acquired TSEA
An important question is how do FDCs acquire TSE agents following intestinal delivery, since FDCs are resident cells in B-cell follicles of organized lymphoid tissues (i.e. not peripheral tissues). TSE agents must first cross the intestinal epithelial barrier and be transported via lymphatics to the draining mesenteric nodes, or via the blood stream to the spleen (which lacks afferent lymphatic drainage). Transport of whole proteins or particles across intact epithelium is very inefficient. Thus it seems unlikely that passive transport across the epithelium and random distribution via the blood or lymph would suffice to deliver sufficient infective material to the lymphoid organs to initiate an infection.
Intestinal epithelium consists of a continuous sheet with individual cells joined by tight junctions. It forms an effective barrier to the movement of molecules and particles into the underlying connective tissues. The seal is however by no means complete, and it is possible that small amounts of macromolecules do transverse the epithelial barrier by transcytosis. In Peyer's patches and intestinal lymphoid follicles, the overlying epithelium is specialized to facilitate the transport of macromolecules and particles, and their delivery to lymphocytes and antigen presenting cells (APC)
including DC. This transport is mediated by M cells, specialized epithelial cells that have poorly developed microvilli and that are able to rapidly transcytose tracers such as horse-radish peroxidase and fluorescent latex particles to the subjacent areas of the patch [66] . The ability of M cells to transport particles and macromolecules has been 'hi-jacked' by a number of intestinal pathogens to enable them to across the epithelia barrier [67] [68] [69] [70] [71] [72] .
Migrating intestinal dendritic cells transport PrP Sc from the gut
It is important not to confuse follicular DC with the 'conventional' DC also known as the 'Steinman' DC [73, 74] . As compared in Table 1 , the two types of cells share almost nothing except their 'dendritic' morphology. FDCs are long-lived cells that retain immune complexes on their surface for years and present them to B cells [75] .
They are probably not haematopoietic. In contrast the 'Steinman' DC is a short-lived bone-marrow-derived cell found both in peripheral tissues and in the T cell areas of lymphoid organs. In peripheral tissues, they are actively endocytic [76] and in some circumstances are macropinocytotic, facilitating uptake of large amount of solutes and small particles [77] . The main function of these cells is to acquire antigens in peripheral tissues and transport them, via draining lymphatics, to secondary lymphoid organs [78] . DCs present processed antigen, as small peptides in association with MHC molecules, primarily to T cells, although they can also present intact antigens to B cells [79] . Some DCs are found to express the normal PrP protein [80, 81] .
Importantly, unlike FDCs, DCs are actively migratory.
Intestinal DCs are bone marrow-derived cells of the 'conventional' DC type, which migrate from the intestinal wall to draining mesenteric nodes. The area of PP underlying the dome is rich in DCs, macrophages and lymphocytes [82, 83] . DCs have also been described in the lamina propria (LP) [84] . Unlike tissue macrophages [85] , DCs spend only a short time (2-4 days) in the intestinal wall, and migrate continuously to mesenteric lymph nodes via lymph. They have been shown to carry antigens acquired from the intestinal lumen [86] , and apoptotic enterocytes [87] . . CD68 is a macrophage marker but it is also expressed at low level on some DCs [88, 89] . By using thoracic duct cannulation of mesenteric lymphadenectomized rats, we have shown that intestinal DC but not T or B lymphocytes could indeed acquire PrP Sc from the intestinal lumen and transport them in lymph towards the mesenteric nodes within hours of oral infection (Fig.1) [90].
It is yet to be determined if DCs acquire PrP Sc after it has been internalised by M cells, or by direct uptake across the mucosal epithelium, as recently shown for the transport of apoptotic intestinal epithelial cells [87] and bacteria [91] . At least some 
Natural barriers for oral prion entry?
In the experiment described above in which we could show PrP Sc in DCs after intestinal delivery, we were unable to show that they contained infective material 
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An alternative explanation for the low efficiency of oral infection is that there may exist strong natural barriers for the pathogen in the gut, including possibly the gastricintestinal enzymes, and the cellular enzymatic activities in DCs. -As shown in Figure   1 , the PrP Sc detected in the DC lysate appears to have been modified in some way and the characteristic three-band molecular signature after PK-treatment is not seen. This may be due, at least in part, to antigen processing in the DCs, since we have also demonstrated in vitro uptake of prion proteins by DCs leads to denaturation of the protein, followed by a time-dependent reduction in PrP Sc detectable by immunoblotting ( Fig.2) resistance to other proteases such as trypsin has also been demonstrated [98] . PK is however a fungal enzyme extracted from a mould (Tritirachium alnum). The enzymes in the cellular compartment and particularly gastro-intestinal tract are complex and identification of those responsible for PrP Sc degradation may be of therapeutic significance. It is also essential of course to determine whether the reduced immunoreactivity detected in DCs also correlates with diminished infectivity as previously reported for macrophages [99, 100] .
These findings suggest that apart from the physical barrier formed by intestinal epithelium mentioned above, intracellular and possibly gastric-intestinal enzymes may be able to degrade prions -providing a natural barrier for prion entry that seems to have been largely overlooked previously. This barrier may explain the relative inefficiency often observed for oral/intragastric inoculation with TSE agents [10] . It 14 may also explain why despite many people in the UK consuming infected beef only a very limited number of people have so far developed nvCJD and why a decline in nvCJD cases [101] rather than an epidemic as previously predicted [102, 103] appears to be the current trend. Nevertheless, whereas transmission of BSE to human (causing nvCJD), and of scrapie to laboratory animals, via the oral route seems to have been relatively inefficient, transmission of BSE to cattle appears to have occurred much more readily, as this was the mode of transmission that led to the epidemic of BSE.
Furthermore, as mentioned above, splenic PrP Sc accumulation or replication does not appear to be necessary in the BSE-cattle transmission. An interesting and important question one may ask is therefore does this imply that cattle are somehow lacking in such degradative enzymes.
Inflammation -"danger" in another way?
The conclusion to be drawn from above findings is that the transmission of prion disease, especially via the oral route, may depend critically on a balance between clearance and propagation of the agent in the host. The normal intestinal immune system displays a balance in which pro-inflammatory and anti-inflammatory cells and molecules are carefully regulated to promote immunity against harmful invading pathogens while avoiding responses to self tissues and harmless dietary components [104] . The lack of inflammatory response in oral TSE infection may prevent the activation of macrophages whose phagocytic, enzymatic as well as phago-lysosomal fusion activities can be up-regulated by inflammation, speeding up the clearance process of the agent. It has been shown recently that the prion protein fragment 106-126 is a chemoattractant for monocyte-derived immature but not mature DCs [105, 15 106] , and on which the receptor has also been identified [105] . This might mean that the initial migration of immature DCs towards PrP Sc can be regulated by the agent itself in the absence of overt inflammation. On the other hand the prion fragment can also enhance subsequent monocyte production of proinflammatory cytokines [105] .
Inflammation stimulates the migration and maturation of DCs, which facilitates the transport of prion, and it is known that antigen processing is down-regulated in mature DC. The effects of inflammation may therefore alter the balance of prion uptake, retention and transport by DCs in several different ways, depending possibly on the stages of their transmission, DC maturation, and perhaps selectivity in the inflammatory mediators involved. It would make sense that the observed effects of immunosuppressive drugs on TSE susceptibility [36] could be due to their actions on the inflammatory machinery rather than the specific (B/T cells) immune system [107] .
Therapeutic and preventive prospects
As described above recent evidence has indicated a role of DCs in delivering and possibly propagating prions following oral inoculation. One should remember however that the main function of DC is to initiate immune responses. Prion-infected animals can develop normal immune responses, both humoral and cellular, to conventional antigens or mitogens [108, 109] but the absence of immune reaction to PrP Sc is not surprising as it differs from the PrP C molecule only in tertiary structure.
The fact that PrP C is a host-encoded protein and the immune system is presumably already tolerized to the molecule explains the lack of response.
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However it is quite possible that although T cells are tolerized, B cells are not. This is 
